Also apoptotic pathways seem to differ between EBV-positive and -negative PTLD: proapoptotic Bim, a critical regulator of lymphocyte survival [107], and apoptosis effector cleaved PARP were shown to be downregulated in EBV-associated PTLD [108]. Here, BCL2L11 is linked to post-transplant lymphoproliferative disease.